Antisense olignucleotides having tumorigenicity-inhibiting activity
US6054439A · kind A · utility
21Cited by
0References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 17, 1998 |
| Grant date | Apr 25, 2000 |
| Priority date | — |
| Expiry date | Feb 17, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/315
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention encompasses tumorigenicity-inhibiting antisense oligonucleotide sequences complementary to mRNA or double-stranded DNA that encodes mammalian DNA methyl transferase. It further encompasses methods for inhibiting tumorigenicity and pharmaceutical composition comprising the tumorigenicity-inhibiting antisense nucleotide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.